benefits of low dose semaglutide for weight loss | Blog Semaglutide - Uses | Limitations
Description
On analysis of secondary endpoints, subjects who continued to receive tirzepatide after randomization had a mean weight loss totaling 26.0% from enrollment through the entire 88-week period of the trial
Elimination Route Mainly excreted in urine and feces
Our published research found that members taking semaglutide alongside this support achieved an average of 19.1% weight loss at 12 months, with 77.7% reaching at least 10% weight loss
As one of the most advanced treatments available, GLP-1s offer a powerful solution for individuals seeking to shed excess pounds and achieve a healthier lifestyle
New England Journal of Medicine, 375(19), 1834 to 1844
